Form 4 for LDOS Leidos
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001628280-25-012083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-07 | LDOS | Cage Christopher R | CFO | A - Grant | $0.00 | +3,758 | 47.6K | +9% | $0 |
| DI | 2025-03-11 | 2025-03-07 | LDOS | Cage Christopher R | CFO | A - Grant | $0.00 | +3,758 | 29.2K | +15% | $0 |
| D | 2025-03-11 | 2025-03-08 | LDOS | Cage Christopher R | CFO | F - Tax | $139.24 | -696 | 47.0K | -1% | -$96.9K |
| D | 2025-03-11 | 2025-03-07 | LDOS | Cage Christopher R | CFO | A - Grant | $0.00 | +11.8K | 11.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | A | A | 3,758 | $0.00 | 47,649 | D By Key Executive Stock Deferral Plan | — | — | (F1) The restricted stock units will vest in full three years from the grant date. |
| 2 | Common | Common Stock | 2025-03-07 | A | A | 3,758 | $0.00 | 29,151.05 | I | — | — | (F1) The restricted stock units will vest in full three years from the grant date. |
| 3 | Common | Common Stock | 2025-03-08 | F | D | 696 | $139.24 | 46,953 | D | — | — | (F2) These shares were withheld by the Company to satisfy the reporting person's tax obligation associated with previously reported awards of restricted stock units. This share withholding was authorized in the restricted stock award agreement. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-03-07 | A | A | 11,763 | $0.00 | 11,763 | D | $133.06 · 2026-03-07 to 2032-03-06 | 11,763 Common Stock | (F3) The options vest and become exercisable in 33 1/3% over three annual installments, beginning on March 7, 2026. |